Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats

International Journal of Food Microbiology

Volumn 144, Issue 3, 2011, Pages 342-351

  Salazar, Nuria ^a   Binetti, Ana ^a,d   Gueimonde, Miguel ^a   Alonso, Ana ^b   Garrido, Pablo ^b   González del Rey, Carmen ^c   González, Celestino ^b   Ruas Madiedo, Patricia ^a   De los Reyes Gavilán, Clara G ^a  

^a CSIC   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c San Agustin Hospital   (Spain)

^d UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

Bifidobacterium; Exopolysaccharide; Intestinal microbiota; Modulation; Wistar rats

Indexed keywords

EXOPOLYSACCHARIDE; SHORT CHAIN FATTY ACID;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM LONGUM; CONTROLLED STUDY; DNA ISOLATION; ENZYME ACTIVITY; HISTOPATHOLOGY; INTESTINE FLORA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLATE COUNT; POLYMERASE CHAIN REACTION; RAT;

ANIMALS; BACTERIAL LOAD; BIFIDOBACTERIUM; FECES; GASTROINTESTINAL TRACT; INTESTINES; MALE; METAGENOME; MICROBIAL VIABILITY; PROBIOTICS; RATS; RATS, WISTAR; REFRIGERATION; SAFETY;

BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; BIFIDOBACTERIUM LONGUM; RATTUS; RATTUS NORVEGICUS;

EID: 78650029085     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.10.016     Document Type: Article

References (46)

1. Ammor M.S., Flórez A.B., van Hoek A.H., de Los Reyes-Gavilán C.G., Aarts H.J., Margolles A., Mayo B. Molecular characterization of intrinsic and acquired antibiotic resistance in lactic acid bacteria and bifidobacteria. Journal of Molecular Microbiology and Biotechnology 2008, 14:6-15.
2. Bäckhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
3. Bryan L.E., Kwan S. Mechanisms of aminoglycoside resistance of anaerobic bacteria and facultative bacteria grown anaerobically. The Journal of Antimicrobial Chemotherapy 1981, 8(Suppl. D):1-8.
4. De los Reyes-Gavilán, C.G., Suárez, A., Fernández-García, M., Margolles, A., Gueimonde, M., Ruas-Madiedo, P., submitted for publication. Behaviour of Bifidobacterium strains with acquired resistance to bile through the simulated gastrointestinal transit using human juices and adhesion to the human intestinal HT29-MTX cell line. Research in Microbiology.
5. Delgado S., Flórez A.B., Mayo B. Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from human gastrointestinal tract. Current Microbiology 2005, 50:202-207.
6. Delgado S., O'Sullivan E., Fitzgerald G., Mayo B. In vitro evaluation of the probiotic properties of human Bifidobacterium species and selection on new probiotic candidates. Journal of Applied Microbiology 2008, 104:1119-1127.
7. Delroisse J.M., Boulvin A.L., Parmentier I., Duaphi R.D., Vandenbol M., Portetelle D. Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real time PCR. Microbiological Research 2008, 163:663-670.
8. EFSA Introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA. The EFSA Journal 2007, 587:1-16.
9. FAO/WHO, 2006. Probiotics in food. Health and nutritional properties and guidelines for evaluation. FAO Food and Nutrition Paper No. 85 (ISBN 92-5-105513-0).
10. Favier C.F., Vaughan E.E., de Vos W.M., Akkermans A.D.L. Molecular monitoring of succession of bacterial communities in human neonates. Applied and Environmental Microbiology 2002, 68:219-226.
11. Fernández M.F., Boris S., Barbés C. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. Journal of Applied Microbiology 2003, 94:449-455.
12. Flórez A.B., Ammor M.S., Álvarez-Martín P., Margolles A., Mayo B. Molecular analysis of tet(W) gene-mediated tetracycline resistance in dominant intestinal Bifidobacterium species from healthy humans. Applied and Environmental Microbiology 2006, 72:7377-7379.
13. Gueimonde M., Delgado S., Mayo B., Ruas-Madiedo P., Margolles A., de los Reyes-Gavilán C.G. Viability and diversity of probiotic Lactobacillus and Bifidobacterium populations included in commercial fermented milks. Food Research International 2004, 37:839-850.
14. Gueimonde M., Tölkö S., Korpimäki T., Salminen S. New real-time quantitative PCR procedure for the quantification of bifidobacteria in human fecal samples. Applied and Environmental Microbiology 2004, 70:4165-4169.
15. Gueimonde M., Debor L., Tölkö S., Jokisalo E., Salminen S. Quantitative assessment of faecal bifidobacterial populations by real-time PCR using lanthanide probes. Journal of Applied Microbiology 2006, 102:116-1122.
16. Gueimonde M., Flórez A.B., van Hoek A.H.A.M., Stuer-Lauridsen B., Strøman P., de los Reyes-Gavilán C.G., Margolles A. Genetic basis of tetracycline resistance in Bifidobacterium animalis subsp. lactis. Applied and Environmental Microbiology 2010, 76:3364-3369.
17. Huang Y., Kotula L., Adams M.C. The in vivo assessment of safety and gastrointestinal survival of an orally administered novel probiotic Propionibacterium jensenii 702 in a male Wistar rat model. Food and Chemical Toxicology 2003, 41:1781-1787.
18. Jayamanne V.S., Adams M.R. Modelling the effects of pH, storage temperature and redox potential (E-h) on the survival of bifidobacteria in fermented milk. International Journal of Food Science & Technology 2009, 44:1131-1138.
19. Juskiewicz J., Semaskaite A., Zdunczyk A., Wroblewska M., Gruzauskas R., Juskiewicz M. Minor effect of the dietary combination of probiotic Pediococcus acidilactici with fructooligosaccharides or polysaccharidases on beneficial changes in the cecum of rats. Nutrition Research 2007, 27:133-139.
20. Klare I., Konstabel C., Müller-Berling S., Reissbrodt R., Huys G., Vancanneryt M., Swings J., Goossens H., Witte W. Evaluation of the new broth media for microdilution antibiotic susceptibility testing of lactobacilli, pediococci, lactococci and bifidobacteria. Applied and Environmental Microbiology 2005, 71:8982-8986.
21. Kumar N.S.N., Balamurugan R., Jayakanthan K., Pulimood A., Pugazhendhi S., Ramakrishna B.S. Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulphate. Gastroenterology 2008, 23:1834-1839.
22. Lahtinen S.J., Gueimonde M., Ouwehand A.C., Reinikainen J.P., Salminen S. Probiotic bacteria may become dormant during storage. Applied and Environmental Microbiology 2005, 71:1662-1663.
23. Lara-Villoslada F., Sierra S., Marí R., Delgado S., Rodríguez J.M., Olivares M., Xaus J. Safety assessment of two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714. Journal of Applied Microbiology 2007, 103:175-184.
24. Lesniewska V., Rowland I., Cani P.D., Neyrinck A.M., Delzene N.M., Naughton P.J. Effect on components of the intestinal microflora and plasma neuropeptide levels of feeding Lactobacillus delbrueckii, Bifidobacterium lactis, and inulin to adult and elderly rats. Applied and Environmental Microbiology 2006, 72:6533-6538.
25. Licht T.R., Hansen M., Poulsen M., Dragsted L.O. Dietary carbohydrate source influences molecular fingerprints of rat faecal microbiota. BMC Microbiology 2006, 6:98.
26. Liong M.T. Safety of probiotics: translocation and infection. Nutrition Reviews 2008, 66:192-202.
27. Maragkoudakis P.A., Papadelli M., Georgalaki M., Panayotopoulou E.G., Martínez-González B., Mentis A.F., Petraki K., Sgouras D.N., Tsakalidou E. In vitro and in vivo safety evaluation of the bacteriocin producer Streptococcus macedonicus ACA-DC198. International Journal of Food Microbiology 2009, 133:141-147.
28. Masco L., Crockaert C., van Hoorde K., Swings J., Huys G. In vitro assessment of the gastrointestinal transit tolerance of taxonomic reference strains from human origin and probiotic product isolated of Bifidobacterium. Journal of Dairy Science 2007, 90:3572-3578.
29. Mättö J., van Hoek A.H.A.M., Domig K.J., Saarela M., Flórez A.B., Brockmann E., Amtmann E., Mayo B., Aarts H.J.M., Danielsen M. Susceptibility of human and probiotic Bifidobacterium spp. to selected antibiotics as determined by the Etest method. International Dairy Journal 2007, 17:1123-1131.
30. Montesi A., García-Albiach R., Pozuelo M.J., Pintado C., Goñi I., Rotger R. Molecular and microbiological analysis of caecal microbiota in rats fed with diets supplemented either with prebiotics or probiotics. International Journal of Food Microbiology 2005, 98:281-289.
31. Nübel U., Engelen B., Felske A., Snaidr J., Weishuber A., Amann R.I., Ludwig W., Backhaus H. Sequence heterogeneities of genes encoding 16S rRNAs in Paenibacillus polymyxa detected by temperature gradient gel electrophoresis. Journal of Bacteriology 1996, 178:5636-5643.
32. Ouwehand A.C., Bergsma N., Parhiala R., Lahtinen S., Gueimonde M., Finne-Soveri H., Strandberg T., Pitkälä K., Salminen S. Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunology and Medical Microbiology 2008, 53:18-25.
33. Parodi P.W. The role of intestinal bacteria in causation and prevention of cancer: modulation by diet and probiotics. Australian Journal of Dairy Technology 1999, 54:103-121.
34. Plant L., Lam C., Conway P.L., O'Riordan K. Gastrointestinal microbial community shifts observed following oral administration of a Lactobacillus fermentum strain to mice. FEMS Microbiology Ecology 2003, 43:133-140.
35. Ruas-Madiedo P., Gueimonde M., Margolles A., de los Reyes-Gavilán C.G., Salminen S. Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus. Journal of Food Protection 2006, 69:2011-2015.
36. Ruas-Madiedo P., Moreno J.A., Salazar N., Delgado S., Mayo B., Margolles A., de los Reyes-Gavilán C.G. Screening of exopolysaccharide-producing Lactobacillus and Bifidobacterium strains isolated from the human intestinal microbiota. Applied and Environmental Microbiology 2007, 73:4385-4388.
37. Ruas-Madiedo P., Abraham A.G., Mozzi F., de los Reyes-Gavilán C.G. Functionality of exopolysaccharides produced by lactic acid bacteria. Molecular aspects of lactic acid bacteria for traditional a new applications 2008, 137-166. Research Signpost, Kerala, India. B. Mayo, P. López, G. Pérez-Martínez (Eds.).
38. Salazar N., Gueimonde M., Hernández-Barranco A.M., Ruas-Madiedo P., de los Reyes-Gavilán C.G. Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. Applied and Environmental Microbiology 2008, 74:4737-4745.
39. Salazar N., Ruas-Madiedo P., Kolida S., Collins M., Rastall R., Gibson G., de los Reyes-Gavilan C.G. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures. International Journal of Food Microbiology 2009, 135:260-267.
40. Sánchez B., Ruiz L., de los Reyes-Gavilán C.G., Margolles A. Proteomics of stress response in Bifidobacterium. Frontiers in Biosciences 2008, 13:6905-6919.
41. Sarmiento-Rubiano L.A., Zúñiga M., Pérez-Martínez G., Yebra M.J. Dietary supplementation with sorbitol results in selective enrichment of lactobacilli in rat intestine. Research in Microbiology 2007, 158:694-701.
42. Tsai C.C., Chen M.H., Liu T.H., Chau C.G., Chang L.T., Tsai C.C. Evaluation of the toxicity of Lactobacillus acidophilus LAP5 in 28-days feeding study in Wistar rats. Journal of Food Safety 2004, 24:268-280.
43. Vanhoutte T., Huys G., de Brant E., Swings J. Temporal stability analysis of the microbiota in human faeces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiology Ecology 2004, 48:437-446.
44. Vasquez N., Suau A., Magne F., Pochart P., Pélissier M.A. Differential effect of Bifidobacterium pseudolongum strain Patronus and metronidazole in the rat gut. Applied and Environmental Microbiology 2009, 75:381-386.
45. Wong J.M., de Souza R., Kendall C.W., Emam A., Jenkins D.J. Colonic health: fermentation and short chain fatty acids. Journal of Clinical Gastroenterology 2006, 40:235-243.
46. Zhou J.S., Shu Q., Rutherfurd K.J., Prasad J., Birtles M.J., Gopal P.K., Gill H.S. Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice. International Journal of Food Microbiology 2000, 56:87-96.